Header
Ihr Suchergebnis
Sie recherchieren derzeit unangemeldet.Melden Sie sich an (Login) um den vollen Funktionsumfang der Datenbank nutzen zu können.
Sie suchen in allen Bereichen nach dem Autor Riihimäki PhD T.
In der Rubrik Zeitschriften haben wir 1 Beitrag für Sie gefunden
-
EU MDR Article 117: Are Our Remits Clear?
Rubrik: europharm
(Treffer aus pharmind, Nr. 08, Seite 686 (2025))
EU MDR Article 117: Are Our Remits Clear? / Roles and Responsibilities · Riihimäki PhD T · Pharmalex Finland Oy
Combination Products EMA Notified Bodies Regulatory Drug Delivery Combination products (CPs) have the potential to transform the therapeutic landscape by bringing innovative therapies and drug delivery systems to patients. These combinations can improve safety, effectiveness, and patient adherence through controlled drug release, targeted delivery, and user-friendly designs. The global drug-device combination products market was valued at approximately 151.57 billion dollars in 2024 and is projected to reach around 165.26 billion dollars in 2025. It is expected to grow to approximately 355.84 billion dollars by 2034, with a compound annual growth rate (CAGR) of 8.91 % from 2025 to 2034 [ 1 ]. The growth is ...
